Farmagen Ar-Ge Biyot. Ltd. Sti Report issue

For profit Phase 1
Founded: Gaziantep Turkey (2016)
Status: No NME R&D (2016)

Organization Overview

First Clinical Trial
2019
NCT04639869
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Farmagen Ar-Ge Biyot. Ltd. Sti

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malnutrition (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 8
  • # of Trial APIs: 5